vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and Inogen Inc (INGN). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $39.9M, roughly 1.7× HARTE HANKS INC). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -15.4%). HARTE HANKS INC produced more free cash flow last quarter ($-686.0K vs $-1.9M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

HHS vs INGN — Head-to-Head

Bigger by revenue
INGN
INGN
1.7× larger
INGN
$68.6M
$39.9M
HHS
Growing faster (revenue YoY)
INGN
INGN
+18.8% gap
INGN
3.4%
-15.4%
HHS
More free cash flow
HHS
HHS
$1.2M more FCF
HHS
$-686.0K
$-1.9M
INGN
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HHS
HHS
INGN
INGN
Revenue
$39.9M
$68.6M
Net Profit
$2.2M
Gross Margin
51.4%
Operating Margin
-0.3%
-13.6%
Net Margin
5.5%
Revenue YoY
-15.4%
3.4%
Net Profit YoY
EPS (diluted)
$0.30
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
INGN
INGN
Q4 25
$39.9M
$68.6M
Q3 25
$39.5M
$79.1M
Q2 25
$38.6M
$79.2M
Q1 25
$41.6M
$68.5M
Q4 24
$47.1M
$66.3M
Q3 24
$47.6M
$74.9M
Q2 24
$45.0M
$74.4M
Q1 24
$45.4M
$63.1M
Net Profit
HHS
HHS
INGN
INGN
Q4 25
$2.2M
Q3 25
$-2.3M
$-5.3M
Q2 25
$-335.0K
$-4.2M
Q1 25
$-392.0K
$-6.2M
Q4 24
Q3 24
$142.0K
$-6.0M
Q2 24
$-27.8M
$-5.6M
Q1 24
$-171.0K
$-14.6M
Gross Margin
HHS
HHS
INGN
INGN
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
HHS
HHS
INGN
INGN
Q4 25
-0.3%
-13.6%
Q3 25
1.3%
-9.0%
Q2 25
0.1%
-7.7%
Q1 25
-0.1%
-11.2%
Q4 24
-3.3%
-17.2%
Q3 24
4.0%
-10.4%
Q2 24
3.0%
-9.5%
Q1 24
0.8%
-25.8%
Net Margin
HHS
HHS
INGN
INGN
Q4 25
5.5%
Q3 25
-5.8%
-6.7%
Q2 25
-0.9%
-5.2%
Q1 25
-0.9%
-9.0%
Q4 24
Q3 24
0.3%
-8.0%
Q2 24
-61.8%
-7.5%
Q1 24
-0.4%
-23.1%
EPS (diluted)
HHS
HHS
INGN
INGN
Q4 25
$0.30
$-0.26
Q3 25
$-0.31
$-0.20
Q2 25
$-0.05
$-0.15
Q1 25
$-0.05
$-0.25
Q4 24
$-0.31
$-0.41
Q3 24
$0.02
$-0.25
Q2 24
$-3.84
$-0.24
Q1 24
$-0.02
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$5.6M
$103.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.5M
$192.2M
Total Assets
$91.8M
$298.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
INGN
INGN
Q4 25
$5.6M
$103.7M
Q3 25
$6.5M
$106.5M
Q2 25
$4.8M
$103.7M
Q1 25
$9.0M
$118.9M
Q4 24
$9.8M
$113.8M
Q3 24
$5.9M
$105.7M
Q2 24
$11.0M
$97.9M
Q1 24
$11.5M
$107.4M
Stockholders' Equity
HHS
HHS
INGN
INGN
Q4 25
$20.5M
$192.2M
Q3 25
$19.9M
$197.2M
Q2 25
$22.2M
$199.5M
Q1 25
$21.4M
$198.0M
Q4 24
$21.7M
$173.9M
Q3 24
$21.0M
$185.4M
Q2 24
$20.6M
$187.6M
Q1 24
$20.0M
$191.9M
Total Assets
HHS
HHS
INGN
INGN
Q4 25
$91.8M
$298.6M
Q3 25
$92.7M
$307.0M
Q2 25
$95.0M
$312.0M
Q1 25
$100.6M
$308.4M
Q4 24
$101.8M
$296.2M
Q3 24
$108.1M
$306.2M
Q2 24
$109.7M
$308.9M
Q1 24
$113.4M
$315.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
INGN
INGN
Operating Cash FlowLast quarter
$737.0K
$-943.0K
Free Cash FlowOCF − Capex
$-686.0K
$-1.9M
FCF MarginFCF / Revenue
-1.7%
-2.8%
Capex IntensityCapex / Revenue
3.6%
1.4%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
INGN
INGN
Q4 25
$737.0K
$-943.0K
Q3 25
$3.2M
$2.2M
Q2 25
$-4.8M
$4.3M
Q1 25
$-818.0K
$-16.8M
Q4 24
$4.0M
$-3.0M
Q3 24
$-2.9M
$7.0M
Q2 24
$1.6M
$6.7M
Q1 24
$-5.7M
$-4.7M
Free Cash Flow
HHS
HHS
INGN
INGN
Q4 25
$-686.0K
$-1.9M
Q3 25
$2.2M
$1.6M
Q2 25
$-5.1M
$3.7M
Q1 25
$-923.0K
$-17.1M
Q4 24
$3.4M
$-3.3M
Q3 24
$-4.9M
$5.3M
Q2 24
$926.0K
$6.6M
Q1 24
$-6.2M
$-6.1M
FCF Margin
HHS
HHS
INGN
INGN
Q4 25
-1.7%
-2.8%
Q3 25
5.5%
2.0%
Q2 25
-13.1%
4.6%
Q1 25
-2.2%
-24.9%
Q4 24
7.3%
-5.0%
Q3 24
-10.2%
7.1%
Q2 24
2.1%
8.9%
Q1 24
-13.7%
-9.6%
Capex Intensity
HHS
HHS
INGN
INGN
Q4 25
3.6%
1.4%
Q3 25
2.5%
0.7%
Q2 25
0.6%
0.9%
Q1 25
0.3%
0.4%
Q4 24
1.3%
0.5%
Q3 24
4.0%
2.2%
Q2 24
1.5%
0.1%
Q1 24
1.2%
2.1%
Cash Conversion
HHS
HHS
INGN
INGN
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons